RUPERTO NICOLINO
Pubblicazioni
Naddei, R., Ridella, F., Bovis, F., Trincianti, C., Avrusin, I., Januskeviciute, G., et al. (2025). Development and initial validation of parent and child versions of the Juvenile Arthritis Disease Activity Score. RHEUMATOLOGY, 64(4), 2143-2152 [10.1093/rheumatology/keae326]. Dettaglio
Eloseily, E., Pickering, A., Dhakal, S., Ruperto, N., Brunner, H., Grom, A., et al. (2025). Transcriptional Profiling of Tofacitinib Treatment in Juvenile Idiopathic Arthritis: Implications for Treatment Response Prediction. ARTHRITIS CARE & RESEARCH, 77(4 (April 2025)), 513-521 [10.1002/acr.25459]. Dettaglio
Baldo, F., Erkens, R., Mizuta, M., Rogani, G., Lucioni, F., Bracaglia, C., et al. (2025). Current treatment in macrophage activation syndrome worldwide: a systematic literature review to inform the METAPHOR project. RHEUMATOLOGY, 64(1), 32-44 [10.1093/rheumatology/keae391]. Dettaglio
De Lisa, R., de Andres-Trelles, F., Bax, R., Galluzzo, S., Alward, B., Thomson, A., et al. (2025). New medicines for childhood-onset systemic lupus erythematosus: an EU perspective on paediatric drug development. FRONTIERS IN MEDICINE, 12 [10.3389/fmed.2025.1583140]. Dettaglio
Rypdal, V., Brunner, H., Feldman, B., Ruperto, N., Aggarwal, A., Angeles-Han, S., et al. (2025). Physician's global assessment of disease activity in juvenile idiopathic arthritis: consensus-based recommendations from an international task force. ANNALS OF THE RHEUMATIC DISEASES, 84(8), 1425-1436 [10.1016/j.ard.2025.01.013]. Dettaglio